Atlas Trials

A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

Clinical trial NCT05907044 · COMPLETED

Trial details

NCT number
NCT05907044
Sponsor
Affiliated Hospital of Yunnan University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2023-05-08
Primary completion
2023-06-10
Enrollment
376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.